These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 24912819

  • 1. Therapeutic effect of a multi-targeted imidazolium compound in hepatocellular carcinoma.
    Gopalan B, Narayanan K, Ke Z, Lu T, Zhang Y, Zhuo L.
    Biomaterials; 2014 Aug; 35(26):7479-87. PubMed ID: 24912819
    [Abstract] [Full Text] [Related]

  • 2. Leptin induces proliferation and anti-apoptosis in human hepatocarcinoma cells by up-regulating cyclin D1 and down-regulating Bax via a Janus kinase 2-linked pathway.
    Chen C, Chang YC, Liu CL, Liu TP, Chang KJ, Guo IC.
    Endocr Relat Cancer; 2007 Jun; 14(2):513-29. PubMed ID: 17639064
    [Abstract] [Full Text] [Related]

  • 3. Targeting the epidermal growth factor receptor by gefitinib for treatment of hepatocellular carcinoma.
    Höpfner M, Sutter AP, Huether A, Schuppan D, Zeitz M, Scherübl H.
    J Hepatol; 2004 Dec; 41(6):1008-16. PubMed ID: 15582135
    [Abstract] [Full Text] [Related]

  • 4. Upregulation of HIF-2α induced by sorafenib contributes to the resistance by activating the TGF-α/EGFR pathway in hepatocellular carcinoma cells.
    Zhao D, Zhai B, He C, Tan G, Jiang X, Pan S, Dong X, Wei Z, Ma L, Qiao H, Jiang H, Sun X.
    Cell Signal; 2014 May; 26(5):1030-9. PubMed ID: 24486412
    [Abstract] [Full Text] [Related]

  • 5. Inhibitory effect of oleanolic acid on hepatocellular carcinoma via ERK-p53-mediated cell cycle arrest and mitochondrial-dependent apoptosis.
    Wang X, Bai H, Zhang X, Liu J, Cao P, Liao N, Zhang W, Wang Z, Hai C.
    Carcinogenesis; 2013 Jun; 34(6):1323-30. PubMed ID: 23404993
    [Abstract] [Full Text] [Related]

  • 6. GYY4137, a hydrogen sulfide (H₂S) donor, shows potent anti-hepatocellular carcinoma activity through blocking the STAT3 pathway.
    Lu S, Gao Y, Huang X, Wang X.
    Int J Oncol; 2014 Apr; 44(4):1259-67. PubMed ID: 24535538
    [Abstract] [Full Text] [Related]

  • 7. Sinomenine hydrochloride inhibits human hepatocellular carcinoma cell growth in vitro and in vivo: involvement of cell cycle arrest and apoptosis induction.
    Lu XL, Zeng J, Chen YL, He PM, Wen MX, Ren MD, Hu YN, Lu GF, He SΧ.
    Int J Oncol; 2013 Jan; 42(1):229-38. PubMed ID: 23165705
    [Abstract] [Full Text] [Related]

  • 8. Caffeine inhibits the proliferation of liver cancer cells and activates the MEK/ERK/EGFR signalling pathway.
    Okano J, Nagahara T, Matsumoto K, Murawaki Y.
    Basic Clin Pharmacol Toxicol; 2008 Jun; 102(6):543-51. PubMed ID: 18346049
    [Abstract] [Full Text] [Related]

  • 9. ψ-Bufarenogin, a novel anti-tumor compound, suppresses liver cancer growth by inhibiting receptor tyrosine kinase-mediated signaling.
    Ding J, Wen W, Xiang D, Yin P, Liu Y, Liu C, He G, Cheng Z, Yin J, Sheng C, Zhang W, Nan F, Ye W, Zhang X, Wang H.
    Oncotarget; 2015 May 10; 6(13):11627-39. PubMed ID: 25890498
    [Abstract] [Full Text] [Related]

  • 10. Total alkaloids of Rubus aleaefolius Poir inhibit hepatocellular carcinoma growth in vivo and in vitro via activation of mitochondrial-dependent apoptosis.
    Zhao J, Chen X, Lin W, Wu G, Zhuang Q, Zhong X, Hong Z, Peng J.
    Int J Oncol; 2013 Mar 10; 42(3):971-8. PubMed ID: 23338043
    [Abstract] [Full Text] [Related]

  • 11. HS-116, a novel phosphatidylinositol 3-kinase inhibitor induces apoptosis and suppresses angiogenesis of hepatocellular carcinoma through inhibition of the PI3K/AKT/mTOR pathway.
    Jung KH, Choi MJ, Hong S, Lee H, Hong SW, Zheng HM, Lee HS, Hong S, Hong SS.
    Cancer Lett; 2012 Mar 28; 316(2):187-95. PubMed ID: 22182943
    [Abstract] [Full Text] [Related]

  • 12. Hemistepsin A Inhibits Cell Proliferation and Induces G0/G1-Phase Arrest, Cellular Senescence and Apoptosis Via the AMPK and p53/p21 Signals in Human Hepatocellular Carcinoma.
    Baek SY, Hwang UW, Suk HY, Kim YW.
    Biomolecules; 2020 May 04; 10(5):. PubMed ID: 32375410
    [Abstract] [Full Text] [Related]

  • 13. AZD6244 enhances the anti-tumor activity of sorafenib in ectopic and orthotopic models of human hepatocellular carcinoma (HCC).
    Huynh H, Ngo VC, Koong HN, Poon D, Choo SP, Toh HC, Thng CH, Chow P, Ong HS, Chung A, Goh BC, Smith PD, Soo KC.
    J Hepatol; 2010 Jan 04; 52(1):79-87. PubMed ID: 19910069
    [Abstract] [Full Text] [Related]

  • 14. The monoclonal antibody CH12 augments 5-fluorouracil-induced growth suppression of hepatocellular carcinoma xenografts expressing epidermal growth factor receptor variant III.
    Jiang H, Dong Q, Luo X, Shi B, Wang H, Gao H, Kong J, Zhang J, Li Z.
    Cancer Lett; 2014 Jan 01; 342(1):113-20. PubMed ID: 24007863
    [Abstract] [Full Text] [Related]

  • 15. Insulin-like growth factor-1 receptor inhibition induces a resistance mechanism via the epidermal growth factor receptor/HER3/AKT signaling pathway: rational basis for cotargeting insulin-like growth factor-1 receptor and epidermal growth factor receptor in hepatocellular carcinoma.
    Desbois-Mouthon C, Baron A, Blivet-Van Eggelpoël MJ, Fartoux L, Venot C, Bladt F, Housset C, Rosmorduc O.
    Clin Cancer Res; 2009 Sep 01; 15(17):5445-56. PubMed ID: 19706799
    [Abstract] [Full Text] [Related]

  • 16. Total alkaloids of Rubus aleaefolius Poir. inhibit the STAT3 signaling pathway leading to suppression of proliferation and cell cycle arrest in a mouse model of hepatocellular carcinoma.
    Zhao J, Lin W, Cao Z, Liu L, Zhuang Q, Zhong X, Hong Z, Peng J.
    Oncol Rep; 2013 Sep 01; 30(3):1309-14. PubMed ID: 23828071
    [Abstract] [Full Text] [Related]

  • 17. Antitumor activity of acriflavine in human hepatocellular carcinoma cells.
    Lee CJ, Yue CH, Lin YY, Wu JC, Liu JY.
    Anticancer Res; 2014 Jul 01; 34(7):3549-56. PubMed ID: 24982368
    [Abstract] [Full Text] [Related]

  • 18. Both antiangiogenesis- and angiogenesis-independent effects are responsible for hepatocellular carcinoma growth arrest by tyrosine kinase inhibitor PTK787/ZK222584.
    Liu Y, Poon RT, Li Q, Kok TW, Lau C, Fan ST.
    Cancer Res; 2005 May 01; 65(9):3691-9. PubMed ID: 15867364
    [Abstract] [Full Text] [Related]

  • 19. Metal-free imidazolium salts inhibit the growth of hepatocellular carcinoma in a mouse model.
    Gopalan B, Ke Z, Zhang C, Kng Y, Suhaimi NA, Riduan SN, Zhang Y, Zhuo L.
    Lab Invest; 2011 May 01; 91(5):744-51. PubMed ID: 21339744
    [Abstract] [Full Text] [Related]

  • 20. Blockage of epidermal growth factor receptor by quinazoline tyrosine kinase inhibitors suppresses growth of human hepatocellular carcinoma.
    Liu Y, Poon RT, Shao W, Sun X, Chen H, Kok TW, Fan ST.
    Cancer Lett; 2007 Apr 08; 248(1):32-40. PubMed ID: 16837130
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.